WINDTREE THERAPEUTICS INC /DE/ Increase (Decrease) in Accounts Receivable
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Increase (Decrease) in Accounts Receivable of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2016-03-29
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in accounts receivable for the quarter ending 2015-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in accounts receivable for the quarter ending 2015-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in accounts receivable for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in accounts receivable for the quarter ending 2015-03-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in accounts receivable for fiscal 2015 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in accounts receivable for fiscal 2014 was -$67.00K, a 200.00% decline from fiscal 2013.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in accounts receivable for fiscal 2013 was $67.00K.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in accounts receivable for fiscal 2012 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $0.00 derived: sum of 2 quarters · filed 2016-03-29 | $0.00 derived: sum of 3 quarters · filed 2016-03-29 | $0.00 10-K · filed 2016-03-29 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | -$22.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | -$22.00K derived: sum of 3 quarters · filed 2016-03-29 | -$41.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | -$22.00K derived: sum of 2 quarters · filed 2016-03-29 | -$41.00K derived: sum of 3 quarters · filed 2016-03-29 | $0.00 derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$41.00K derived: sum of 2 quarters · filed 2016-03-29 | $0.00 derived: sum of 3 quarters · filed 2016-03-29 | -$67.00K 10-K · filed 2016-03-29 |
| 2014-09-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $22.00K derived: sum of 2 quarters · filed 2015-11-05 | -$45.00K 10-Q · filed 2015-11-05 | $22.00K derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$26.00K 10-Q · filed 2015-08-10 | $41.00K derived: sum of 3 quarters · filed 2015-08-10 | $41.00K derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | -$67.00K 10-Q · filed 2015-05-11 | $0.00 derived: sum of 2 quarters · filed 2015-05-11 | $0.00 derived: sum of 3 quarters · filed 2015-05-11 | $0.00 derived: sum of 4 quarters · filed 2015-05-11 |
| 2013-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $67.00K derived: sum of 2 quarters · filed 2015-03-16 | $67.00K derived: sum of 3 quarters · filed 2015-03-16 | $67.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-16 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |